Drugs@FDA: FDA Approved Drug Products

Home | Previous Page

Abbreviated New Drug Application (ANDA): 074037
Company: HOSPIRA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ACETYLCYSTEINE ACETYLCYSTEINE 20% SOLUTION;INHALATION, ORAL Prescription AN No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
08/30/1994 ORIG-1 Approval

Label is not available on this site.

Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
01/15/2016 SUPPL-17 Labeling-Package Insert, Labeling-Container/Carton Labels

Label is not available on this site.

08/05/1998 SUPPL-6 Labeling

Label is not available on this site.

02/05/1996 SUPPL-4 Labeling

Label is not available on this site.

02/05/1996 SUPPL-3 Manufacturing (CMC)

Label is not available on this site.

02/05/1996 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

02/05/1996 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

ACETYLCYSTEINE

SOLUTION;INHALATION, ORAL; 20%
TE Code = AN

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ACETYLCYSTEINE ACETYLCYSTEINE 20% SOLUTION;INHALATION, ORAL Prescription No AN 203853 ALVOGEN INC
ACETYLCYSTEINE ACETYLCYSTEINE 20% SOLUTION;INHALATION, ORAL Prescription No AN 074037 HOSPIRA
ACETYLCYSTEINE ACETYLCYSTEINE 20% SOLUTION;INHALATION, ORAL Prescription No AN 072547 LUITPOLD

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English